Skip to main content
. 2024 Jul 18;19(7):e0307282. doi: 10.1371/journal.pone.0307282

Fig 5. Association between recurrent or metastatic cervical cancer burden and presence of at least one brachytherapy center in a ZIP-3 for the period 2017–2022.

Fig 5

Recurrent or metastatic cervical cancer burden was defined as the proportion of patients with cervical cancer who initiated system therapy. r/mCC: recurrent or metastatic cervical cancer.